The stock of Conmed Corp. (NYSE:CNMD) last traded at $80.08, down -0.07% from the previous session.
CNMD stock price is now -5.84% away from the 50-day moving average and -23.68% away from the 200-day moving average. The market capitalization of the company currently stands at $2.46B.
With the price target enhanced from $119 to $129, Needham maintained Buy rating for Conmed Corp. (NYSE: CNMD). On May 22, 2023, CL King recently initiated its ‘Buy’ rating on the stock quoting a target price of $140, while ‘KeyBanc Capital Markets’ rates the stock as ‘Overweight’
In other news, Peters Stanley W III, President AS and AET sold 2,300 shares of the company’s stock on Dec 04 ’23. The stock was sold for $252,833 at an average price of $109.93. Upon completion of the transaction, the President AS and AET now directly owns 63 shares in the company, valued at $5045.04. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 07 ’23, President AS and AET Peters Stanley W III sold 1,200 shares of the business’s stock. A total of $122,874 was realized by selling the stock at an average price of $102.39. This leaves the insider owning 63 shares of the company worth $5045.04. A total of 0.79% of the company’s stock is owned by insiders.
During the past 12 months, Conmed Corp. has had a low of $74.67 and a high of $138.47. As of last week, the company has a debt-to-equity ratio of 1.19, a current ratio of 1.98, and a quick ratio of 0.96. According to the stock market information, the enterprise value for the company is $3.42B, which is based on a 39.26 price-to-earnings ratio, a 1.55 price-to-earnings-growth ratio, and a beta of 1.33. The fifty day moving average price for CNMD is $85.05 and a two-hundred day moving average price translates $104.93 for the stock.
The latest earnings results from Conmed Corp. (NYSE: CNMD) was released for Dec, 2023. According to the Medical Devices Company, earnings per share came in at $1.06, missing analysts’ expectations of $1.11 by -0.05. This compares to $1.06 EPS in the same period last year. The net profit margin was 5.19% and return on equity was 8.16% for CNMD. The company reported revenue of $327.05 million for the quarter, compared to $250.87 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 30.37 percent. For the current quarter, analysts expect CNMD to generate $306.78M in revenue.
